Rheumatologic Disease
Clinical research in rheumatology focuses on adults with moderately to severely active inflammatory disease, including rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis.
- Disease activity reduction
- Joint inflammation
- Functional symptom control
These studies assess clinical response using established measures of arthritis severity and inflammatory burden.
Ulcerative Colitis
The sponsor’s gastroenterology portfolio includes moderate to severe ulcerative colitis, with interest in both histologic improvement and clinical remission.
- Colonic inflammation
- Mucosal healing
- Remission outcomes
Research activity is centered on controlling intestinal disease activity in adults with active inflammatory bowel disease.
Inflammatory Disease Activity Assessment
Across its trials, the sponsor emphasizes validated clinical endpoints that capture changes in inflammatory disease activity in both musculoskeletal and gastrointestinal disorders.
- Clinical remission
- Symptom burden
- Objective disease scoring
These areas reflect a focus on conditions where persistent inflammation drives ongoing tissue damage and patient disability.
Immune-Mediated Therapeutics
The clinical program is situated within immune-mediated disease research, spanning both rheumatologic and intestinal therapeutic domains.
- Autoimmune inflammation
- Targeted biologic therapy
- Chronic inflammatory disorders
Research sites across multiple countries are engaged in evaluating treatments for active disease in these therapeutic areas.
